KIBRA Promotes Prostate Cancer Cell Proliferation and Motility
Overview
Affiliations
KIBRA is a regulator of the Hippo-yes-associated protein (YAP) pathway, which plays a critical role in tumorigenesis. In the present study, we show that KIBRA is a positive regulator in prostate cancer cell proliferation and motility. We found that KIBRA is transcriptionally upregulated in androgen-insensitive LNCaPC4-2 and LNCaP-C81 cells compared to parental androgen-sensitive LNCaP cells. Ectopic expression of KIBRA enhances cell proliferation, migration and invasion in both immortalized and cancerous prostate epithelial cells. Accordingly, knockdown of KIBRA reduces migration, invasion and anchorage-independent growth in LNCaP-C4-2/C81 cells. Moreover, KIBRA expression is induced by androgen signaling and KIBRA is partially required for androgen receptor signaling activation in prostate cancer cells. In line with these findings, we further show that KIBRA is overexpressed in human prostate tumors. Our studies uncover unexpected results and identify KIBRA as a tumor promoter in prostate cancer.
The Hippo pathway: an emerging role in urologic cancers.
Cinar B, Alp E, Al-Mathkour M, Boston A, Dwead A, Khazaw K Am J Clin Exp Urol. 2021; 9(4):301-317.
PMID: 34541029 PMC: 8446764.
WWC Proteins: Important Regulators of Hippo Signaling in Cancer.
Hoffken V, Hermann A, Pavenstadt H, Kremerskothen J Cancers (Basel). 2021; 13(2).
PMID: 33467643 PMC: 7829927. DOI: 10.3390/cancers13020306.
FRMD6 has tumor suppressor functions in prostate cancer.
Haldrup J, Strand S, Cieza-Borrella C, Jakobsson M, Riedel M, Norgaard M Oncogene. 2020; 40(4):763-776.
PMID: 33249427 DOI: 10.1038/s41388-020-01548-w.
Kwok E, Rodriguez D, Kremerskothen J, Nyarko A J Biol Chem. 2019; 294(46):17383-17394.
PMID: 31597702 PMC: 6873182. DOI: 10.1074/jbc.RA119.009589.
Stauffer S, Zeng Y, Santos M, Zhou J, Chen Y, Dong J J Cell Sci. 2019; 132(20).
PMID: 31519809 PMC: 6826014. DOI: 10.1242/jcs.236000.